TOX: a potential new immune checkpoint in cancers by pancancer analysis
TOX, a potential biomarker for cancer, may be involved in the regulation of the immune microenvironment and can be used for new targeted drugs.
Authors
- Dawei Cui (ORCID: https://orcid.org/0000-0003-3840-1486)
- Shengliang Qiu (ORCID: https://orcid.org/0000-0002-4538-594X)
- Jiayang Li (ORCID: https://orcid.org/0000-0001-9271-3988)
- Weiye Lin (ORCID: https://orcid.org/0009-0000-7541-6674)
- Zhengyang Zhou (ORCID: https://orcid.org/0009-0005-4160-3574)
- Qianran Hong (ORCID: https://orcid.org/0009-0007-9132-7218)
- Fengyun Zhong (ORCID: https://orcid.org/0009-0007-9925-1828)
- Shuangyu Chen
- Qinfeng Zhou (ORCID: https://orcid.org/0000-0003-1334-8519)
Institutions
- Zhejiang Chinese Medical University (CN)
- Nanjing University of Chinese Medicine (CN)
- Soochow University (CN)
- Zhangjiagang First People's Hospital (CN)
- Second Affiliated Hospital of Soochow University (CN)
- First Affiliated Hospital Zhejiang University (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2024-08-16
- DOI
- https://doi.org/10.1007/s12672-024-01236-1
- Citations
- 3
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.86
Funders
- National Natural Science Foundation of China